TABLE OF CONTENTS |  |  |  | Volume 108, Issue 6 (1225-1392) Published online 2 April 2013
|  | In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Letters to the Editor
Also new today Advance online publication
| |  |  | Minireview | Top |  | Proton beam therapy and localised prostate cancer: current status and controversies J A Efstathiou, P J Gray and A L Zietman Br J Cancer 2013 108: 1225-1230; advance online publication, March 12, 2013; 10.1038/bjc.2013.100 Abstract | Full Text |  | Clinical Studies | Top |  | BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study J L Lesnock, K M Darcy, C Tian, J A DeLoia, M M Thrall, C Zahn, D K Armstrong, M J Birrer and T C Krivak Br J Cancer 2013 108: 1231-1237; advance online publication, March 5, 2013; 10.1038/bjc.2013.70 Abstract | Full Text |  |  |  | ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy P Li, Y J Fang, F Li, Q J Ou, G Chen and G Ma Br J Cancer 2013 108: 1238-1244; advance online publication, March 12, 2013; 10.1038/bjc.2013.83 Abstract | Full Text |  |  |  | Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201) Y-K Kang, H-M Chang, J H Yook, M-H Ryu, I Park, Y J Min, D Y Zang, G Y Kim, D H Yang, S J Jang, Y S Park, J-L Lee, T W Kim, S T Oh, B K Park, H-Y Jung and B S Kim Br J Cancer 2013 108: 1245-1251; advance online publication, February 28, 2013; 10.1038/bjc.2013.86 Abstract | Full Text |  |  |  | A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma T Meyer, A Kirkwood, M Roughton, S Beare, E Tsochatzis, D Yu, N Davies, E Williams, S P Pereira, D Hochhauser, A Mayer, R Gillmore, J O'Beirne, D Patch and A K Burroughs Br J Cancer 2013 108: 1252-1259; advance online publication, February 28, 2013; 10.1038/bjc.2013.85 Abstract | Full Text |  |  |  | Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma K Yoshimura, T Minami, M Nozawa and H Uemura Br J Cancer 2013 108: 1260-1266; advance online publication, March 7, 2013; 10.1038/bjc.2013.90 Abstract | Full Text |  |  |  | Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer M Koskas, E Chereau, M Ballester, G Dubernard, F Lécuru, D Heitz, P Mathevet, H Marret, D Querleu, F Golfier, E Leblanc, D Luton, R Rouzier and E Daraï Br J Cancer 2013 108: 1267-1272; advance online publication, March 12, 2013; 10.1038/bjc.2013.95 Abstract | Full Text |  |  |  | Does referral to specialist paediatric palliative care services reduce hospital admissions in oncology patients at the end of life? L K Fraser, M van Laar, M Miller, J Aldridge, P A McKinney, R C Parslow and R G Feltbower Br J Cancer 2013 108: 1273-1279; advance online publication, February 28, 2013; 10.1038/bjc.2013.89 Abstract | Full Text |  |  |  | Childhood cancer and factors related to prolonged diagnostic intervals: a Danish population-based study J M Ahrensberg, F Olesen, R P Hansen, H Schrøder and P Vedsted Br J Cancer 2013 108: 1280-1287; advance online publication, February 28, 2013; 10.1038/bjc.2013.88 Abstract | Full Text |  | Translational Therapeutics | Top |  | Using macrophage activation to augment immunotherapy of established tumours Z G Fridlender, A Jassar, I Mishalian, L-CS Wang, V Kapoor, G Cheng, J Sun, S Singhal, L Levy and S M Albelda Br J Cancer 2013 108: 1288-1297; advance online publication, March 12, 2013; 10.1038/bjc.2013.93 Abstract | Full Text |  |  |  | In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours M Quintela-Fandino, M Krzyzanowska, G Duncan, A Young, M J Moore, E X Chen, A Stathis, R Colomer, J Petronis, M Grewal, S Webster, L Wang and L L Siu Br J Cancer 2013 108: 1298-1305; advance online publication, February 14, 2013; 10.1038/bjc.2013.64 Abstract | Full Text |  |  |  | Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) S M Tijono, K Guo, K Henare, B D Palmer, L-C S Wang, S M Albelda and L-M Ching Br J Cancer 2013 108: 1306-1315; advance online publication, March 12, 2013; 10.1038/bjc.2013.101 Abstract | Full Text |  | Molecular Diagnostics | Top |  | Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy J M Jürgensmeier, H-J Schmoll, J D Robertson, L Brooks, M Taboada, S R Morgan, D Wilson and P M Hoff Br J Cancer 2013 108: 1316-1323; advance online publication, February 28, 2013; 10.1038/bjc.2013.79 Abstract | Full Text |  |  |  | Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma Y Nishimura, S Komatsu, D Ichikawa, H Nagata, S Hirajima, H Takeshita, T Kawaguchi, T Arita, H Konishi, K Kashimoto, A Shiozaki, H Fujiwara, K Okamoto, H Tsuda and E Otsuji Br J Cancer 2013 108: 1324-1331; advance online publication, February 19, 2013; 10.1038/bjc.2013.65 Abstract | Full Text |  |  |  | Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma A G Schache, T Liloglou, J M Risk, T M Jones, X-J Ma, H Wang, S Bui, Y Luo, P Sloan, R J Shaw and M Robinson Br J Cancer 2013 108: 1332-1339; advance online publication, February 14, 2013; 10.1038/bjc.2013.63 Abstract | Full Text |  |  |  | The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma L E Dalton, H J Clarke, J Knight, M H Lawson, J Wason, D A Lomas, W J Howat, R C Rintoul, D M Rassl and S J Marciniak Br J Cancer 2013 108: 1340-1347; advance online publication, February 14, 2013; 10.1038/bjc.2013.66 Abstract | Full Text |  |  |  | Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer K Matsuo, S Mabuchi, M Okazawa, Y Matsumoto, T Tsutsui, M Fujita, S Kamiura, K Ogawa, C P Morrow and T Kimura Br J Cancer 2013 108: 1348-1357; advance online publication, March 5, 2013; 10.1038/bjc.2013.78 Abstract | Full Text |  |  |  | Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting D J E Peeters, B De Laere, G G Van den Eynden, S J Van Laere, F Rothé, M Ignatiadis, A M Sieuwerts, D Lambrechts, A Rutten, P A van Dam, P Pauwels, M Peeters, P B Vermeulen and L Y Dirix Br J Cancer 2013 108: 1358-1367; advance online publication, March 7, 2013; 10.1038/bjc.2013.92 Abstract | Full Text |  | Genetics & Genomics | Top |  | Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer L E De Faveri, C D Hurst, F M Platt, C F Taylor, J-A Roulson, M Sanchez-Carbayo, M A Knowles and E J Chapman Br J Cancer 2013 108: 1368-1377; 10.1038/bjc.2013.104 Abstract | Full Text |  |  |  | Common genetic variants in the 9p21 region and their associations with multiple tumours F Gu, R M Pfeiffer, S Bhattacharjee, S S Han, P R Taylor, S Berndt, H Yang, A J Sigurdson, J Toro, L Mirabello, M H Greene, N D Freedman, C C Abnet, S M Dawsey, N Hu, Y-L Qiao, T Ding, A V Brenner, M Garcia-Closas, R Hayes, L A Brinton, J Lissowska, N Wentzensen, C Kratz, L E Moore, R G Ziegler, W-H Chow, S A Savage, L Burdette, M Yeager, S J Chanock, N Chatterjee, M A Tucker, A M Goldstein and X R Yang Br J Cancer 2013 108: 1378-1386; advance online publication, January 29, 2013; 10.1038/bjc.2013.7 Abstract | Full Text |  | Letters to the Editor | Top |  | On the clinical relevance of circulating endothelial cells and platelets in prostate cancer F Bertolini, Y Shaked and P Mancuso Br J Cancer 2013 108: 1387; advance online publication, February 14, 2013; 10.1038/bjc.2012.528 Full Text |  |  |  | Reply: On the clinical relevance of circulating endothelial cells and platelets in prostate cancer C K E Wong, B Namdarian, J Chua, X Chin, R Speirs, T Nguyen, M Fankhauser, J Pedersen, A J Costello, N M Corcoran and C M Hovens Br J Cancer 2013 108: 1388; advance online publication, February 14, 2013; 10.1038/bjc.2012.529 Full Text |  |  |  | False positive result in study on hookah smoking and cancer in Kashmir: measuring risk of poor hygiene is not the same as measuring risk of inhaling water filtered tobacco smoke all over the world K Chaouachi Br J Cancer 2013 108: 1389-1390; advance online publication, March 7, 2013; 10.1038/bjc.2013.98 Full Text |  |  |  | Reply: False positive result in study on hookah smoking and cancer in Kashmir: measuring risk of poor hygiene is not the same as measuring risk of inhaling water-filtered tobacco smoke all over the world N A Dar, F Islami and P Boffetta Br J Cancer 2013 108: 1391-1392; advance online publication, March 7, 2013; 10.1038/bjc.2013.99 Full Text |  |  |  |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment